1. Hepatitis B Prevention & Clinical Management Guidelines* Immunization Schedules for U.S.-Bound Refugees administered by the International Organization for Migration, Aug 2014 (Immigrant, Refugee and Migrant Health Branch, Division of Global Migration and Quarantine, CDC) * Guidelines for the Prevention, Care, and Treatment of Persons with Chronic Hepatitis B Infection (World Health Organization, March 2015)* Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update (January 2015) * Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy (American Gastroenterological Association, October 2014)

2. Hepatitis C News & Resources* A Guide to Comprehensive Hepatitis C Counseling and Testingin Primary Care Settings (CDC) * Local Health Departments and Hepatitis C (National Association of City and County Health Officials, Webinar, May 2015)*Implementing Electronic Medical Record Prompts for Baby Boomer Hep C Screening (National Viral Hepatitis Roundtable, 2015)* Patients infected with hepatitis C after visiting Santa Barbara doctor (LA Times, April 28, 2015)* New Hepatitis C Treatments Have High Cure Rates for African Americans (AIDS.gov, April 24, 2015)

3. Hepatitis C State Policy Updates* CalHEP recommends nearly $9 million of hepatitis C health care assistance for Californians in next years state budget (Project Inform, May 10, 2015)* The Governors May Revision for the 2015-2016 Budget includes $228 million for hepatitis C treatment costs in Medi-Cal, state hospitals, and state prisons. If finalized, the budget would be effective July 1. * Assembly Bill 383 (Gipson, D-Carson) would require primary care clinics to offer hepatitis C screeningin accordance with U.S. Preventive Services Task Force screening guidelines, with some exceptions noted in the bill. For more information and to read the bill, visit leginfo.legislature.ca.gov/.

4. Hepatitis C and HIV/HCV Coinfection Clinical Management Updates* FDA Label Update: Olysio (simeprevir) (FDA, April, 2015) (1) serious symptomatic bradycardia when co-administered with sofosbuvir and amiodarone; and (2) hepatic decompensation and hepatic failure. * FDA Safety Alert: Hepatitis C Treatments Containing Sofosbuvir in Combination With Another Direct Acting Antiviral Drug: Serious Slowing of Heart Rate When Used With Antiarrhythmic Drug Amiodarone. * California Correctional Health Care Services, HCV Care Guide (Updated May 2015)* Delivering Hepatitis C Treatment in an HIV Care Setting (HRSA, 2014)* AASLD/IDSA HCV Treatment Guidelines, HIV Coinfection Section Updated (March 2015)

5. Care and Treatment Resources* Pharmaceutical Company Patient Assistance Programs for Treatment of Hepatitis B and Hepatitis C (National Alliance of State and Territorial AIDS Directors, February 2015)* Blue Cross Withholds Cure from Hepatitis C Patients, Lawsuit Claims (PR Newswire, May 15, 2015)* Your Health Care Rights (California Department of Managed Care)